Inside informationEnglish
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 27/03/2026, 13:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 112659_20260327